Cargando…

Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma

Background: Signal transducer and activator of transcription proteins (STATs) play important roles in gene regulation, cell proliferation, and cell differentiation. We aimed to establish the relationship between phosphorylated STAT3 (p-Ser-STAT3) expression and the prognosis of upper tract urothelia...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei-Ming, Huang, Chun-Nung, Lee, Yi-Chen, Chen, Szu-Han, Lin, Hui-Hui, Wu, Wen-Jeng, Li, Ching-Chia, Yeh, Hsin-Chih, Chang, Lin-Li, Hsu, Wei-Chi, Ke, Hung-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707752/
https://www.ncbi.nlm.nih.gov/pubmed/29200949
http://dx.doi.org/10.7150/ijms.17367
_version_ 1783282503123992576
author Li, Wei-Ming
Huang, Chun-Nung
Lee, Yi-Chen
Chen, Szu-Han
Lin, Hui-Hui
Wu, Wen-Jeng
Li, Ching-Chia
Yeh, Hsin-Chih
Chang, Lin-Li
Hsu, Wei-Chi
Ke, Hung-Lung
author_facet Li, Wei-Ming
Huang, Chun-Nung
Lee, Yi-Chen
Chen, Szu-Han
Lin, Hui-Hui
Wu, Wen-Jeng
Li, Ching-Chia
Yeh, Hsin-Chih
Chang, Lin-Li
Hsu, Wei-Chi
Ke, Hung-Lung
author_sort Li, Wei-Ming
collection PubMed
description Background: Signal transducer and activator of transcription proteins (STATs) play important roles in gene regulation, cell proliferation, and cell differentiation. We aimed to establish the relationship between phosphorylated STAT3 (p-Ser-STAT3) expression and the prognosis of upper tract urothelial carcinoma (UTUC). Methods: This study retrospectively reviewed 100 patients with pathologically confirmed UTUC at Kaohsiung Medical University Hospital. We quantified the expression of p-Ser-STAT3 in cancer cells by immunohistochemistry, and determined the clinicopathological significance of p-Ser-STAT3 expression and prognostic outcomes in patients with UTUC. Results: High p-Ser-STAT3 expression was detected in 52% of UTUC patients. High p-Ser-STAT3 expression was associated with poor recurrence-free survival (p = 0.018) and overall survival (p = 0.026). In advanced cancer samples (stage T3/T4), p-Ser-STAT3 expression is the only independent prognostic factor for recurrence-free survival (hazard ratio = 5.91, p = 0.01) and cancer-specific survival (hazard ratio = 8.83, p = 0.039). Conclusions: The expression of p-Ser-STAT3 can be a potential prognostic marker for cancer recurrence and survival in UTUC, especially in advanced stage cases.
format Online
Article
Text
id pubmed-5707752
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-57077522017-11-30 Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma Li, Wei-Ming Huang, Chun-Nung Lee, Yi-Chen Chen, Szu-Han Lin, Hui-Hui Wu, Wen-Jeng Li, Ching-Chia Yeh, Hsin-Chih Chang, Lin-Li Hsu, Wei-Chi Ke, Hung-Lung Int J Med Sci Research Paper Background: Signal transducer and activator of transcription proteins (STATs) play important roles in gene regulation, cell proliferation, and cell differentiation. We aimed to establish the relationship between phosphorylated STAT3 (p-Ser-STAT3) expression and the prognosis of upper tract urothelial carcinoma (UTUC). Methods: This study retrospectively reviewed 100 patients with pathologically confirmed UTUC at Kaohsiung Medical University Hospital. We quantified the expression of p-Ser-STAT3 in cancer cells by immunohistochemistry, and determined the clinicopathological significance of p-Ser-STAT3 expression and prognostic outcomes in patients with UTUC. Results: High p-Ser-STAT3 expression was detected in 52% of UTUC patients. High p-Ser-STAT3 expression was associated with poor recurrence-free survival (p = 0.018) and overall survival (p = 0.026). In advanced cancer samples (stage T3/T4), p-Ser-STAT3 expression is the only independent prognostic factor for recurrence-free survival (hazard ratio = 5.91, p = 0.01) and cancer-specific survival (hazard ratio = 8.83, p = 0.039). Conclusions: The expression of p-Ser-STAT3 can be a potential prognostic marker for cancer recurrence and survival in UTUC, especially in advanced stage cases. Ivyspring International Publisher 2017-10-15 /pmc/articles/PMC5707752/ /pubmed/29200949 http://dx.doi.org/10.7150/ijms.17367 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Li, Wei-Ming
Huang, Chun-Nung
Lee, Yi-Chen
Chen, Szu-Han
Lin, Hui-Hui
Wu, Wen-Jeng
Li, Ching-Chia
Yeh, Hsin-Chih
Chang, Lin-Li
Hsu, Wei-Chi
Ke, Hung-Lung
Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
title Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
title_full Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
title_fullStr Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
title_full_unstemmed Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
title_short Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
title_sort over-expression of activated signal transducer and activator of transcription 3 predicts poor prognosis in upper tract urothelial carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707752/
https://www.ncbi.nlm.nih.gov/pubmed/29200949
http://dx.doi.org/10.7150/ijms.17367
work_keys_str_mv AT liweiming overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT huangchunnung overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT leeyichen overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT chenszuhan overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT linhuihui overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT wuwenjeng overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT lichingchia overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT yehhsinchih overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT changlinli overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT hsuweichi overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma
AT kehunglung overexpressionofactivatedsignaltransducerandactivatoroftranscription3predictspoorprognosisinuppertracturothelialcarcinoma